h1

000772696 001__ 772696
000772696 005__ 20241230142645.0
000772696 0247_ $$2HSB$$aeva29769
000772696 0247_ $$2ISSN$$a0006-5242
000772696 0247_ $$2ISSN$$a0939-5555
000772696 0247_ $$2ISSN$$a1432-0584
000772696 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85064055378
000772696 0247_ $$2WOS$$aWOS:000467682000007
000772696 0247_ $$2doi$$a10.1007/s00277-019-03651-9
000772696 0247_ $$2pmid$$apmid:30903275
000772696 037__ $$aRWTH-CONV-240230
000772696 041__ $$aEnglish
000772696 1001_ $$aKessler, Torsten$$b0$$eCorresponding author
000772696 245__ $$aPhase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)$$honline, print
000772696 260__ $$aBerlin ; Heidelberg ; New York$$bSpringer$$c2019
000772696 3367_ $$00$$2EndNote$$aJournal Article
000772696 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
000772696 3367_ $$2BibTeX$$aARTICLE
000772696 3367_ $$2DRIVER$$aarticle
000772696 3367_ $$2DataCite$$aOutput Types/Journal article
000772696 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000772696 591__ $$aGermany
000772696 7001_ $$0P:(DE-82)IDM06178$$aKoschmieder, Steffen$$b1$$eCorresponding author$$urwth
000772696 7001_ $$aSchliemann, Christoph$$b2
000772696 7001_ $$0P:(DE-588)136441173$$aCrysandt, Martina$$b3$$urwth
000772696 7001_ $$aMikesch, Jan-Henrik$$b4
000772696 7001_ $$0P:(DE-82)IDM06151$$avon Stillfried, Saskia$$b5$$urwth
000772696 7001_ $$aStelljes, Matthias$$b6
000772696 7001_ $$aPohlen, Michele$$b7
000772696 7001_ $$aLenz, Georg$$b8
000772696 7001_ $$aKirsch, Anna$$b9
000772696 7001_ $$aVehring, Kerstin$$b10
000772696 7001_ $$aWardelmann, Eva$$b11
000772696 7001_ $$aHartmann, Wolfgang$$b12
000772696 7001_ $$aBormann, Eike$$b13
000772696 7001_ $$aGerss, Joachim$$b14
000772696 7001_ $$0P:(DE-82)IDM06025$$aBrümmendorf, Tim Henrik$$b15$$urwth
000772696 7001_ $$0P:(DE-82)067393$$aMüller-Tidow, Carsten$$b16
000772696 7001_ $$aBerdel, Wolfgang E.$$b17$$eCorresponding author
000772696 773__ $$0PERI:(DE-600)1458429-3$$a10.1007/s00277-019-03651-9$$n6$$p1393-1401$$tAnnals of hematology$$v98$$x1432-0584
000772696 909CO $$ooai:publications.rwth-aachen.de:772696$$pVDB
000772696 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06178$$aRWTH Aachen$$b1$$kRWTH
000772696 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-588)136441173$$aRWTH Aachen$$b3$$kRWTH
000772696 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06151$$aRWTH Aachen$$b5$$kRWTH
000772696 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)197071$$aRWTH Aachen$$b15$$kRWTH
000772696 9141_ $$y2019
000772696 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
000772696 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANN HEMATOL : 2021$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-11
000772696 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-11$$wger
000772696 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-11
000772696 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
000772696 9201_ $$0I:(DE-82)531040-3_20140620$$k531040-3$$lLehr- und Forschungsgebiet Translationale Hämatologie und Onkologie$$x1
000772696 961__ $$c2019-11-14$$x2019-11-18$$z2019-11-20
000772696 970__ $$aeva29769
000772696 980__ $$aI:(DE-82)531040-2_20140620
000772696 980__ $$aI:(DE-82)531040-3_20140620
000772696 980__ $$aIMPORT
000772696 980__ $$aUNRESTRICTED
000772696 980__ $$aVDB
000772696 980__ $$ajournal